Question 1

How does pharmacoscopy work and how might it benefit my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacoscopy for Patients With Refractory Primary Brain Tumors clinical trial (NCT06804655). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential risks and side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacoscopy for Patients With Refractory Primary Brain Tumors clinical trial (NCT06804655). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my participation affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacoscopy for Patients With Refractory Primary Brain Tumors clinical trial (NCT06804655). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacoscopy for Patients With Refractory Primary Brain Tumors clinical trial (NCT06804655). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacoscopy for Patients With Refractory Primary Brain Tumors clinical trial (NCT06804655). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I do not respond to the treatment identified through pharmacoscopy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacoscopy for Patients With Refractory Primary Brain Tumors clinical trial (NCT06804655). Contact the study team or your healthcare provider for specific answers.

What this study is about